학술논문
Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial
Document Type
Article
Author
Source
In The Lancet Haematology June 2018 5(6):e261-e269
Subject
Language
ISSN
2352-3026